Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-08 5:08 pm Unchanged | 13D | LENZ Therapeutics Inc. LENZ | Versant Venture Capital VI L.P. | 2,101,199 7.600% | 0 (Unchanged) | View |
| 2024-10-30 5:10 pm Sale | 13D | Monte Rosa Therapeutics Inc. GLUE | Versant Venture Capital VI L.P. | 4,079,469 6.600% | -1,019,867 (-20.00%) | View |
| 2024-09-24 5:00 pm Sale | 13D | Monte Rosa Therapeutics Inc. GLUE | Versant Venture Capital VI L.P. | 5,099,336 8.300% | -1,699,779 (-25.00%) | View |
| 2024-08-12 8:59 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 8.400% | 0 (Unchanged) | View |
| 2024-08-12 5:07 pm Unchanged | 13D | Monte Rosa Therapeutics Inc. GLUE | Versant Venture Capital VI L.P. | 6,799,115 11.100% | 0 (Unchanged) | View |
| 2024-08-09 7:06 pm Sale | 13D | Passage BIO Inc. PASG | Versant Venture Capital VI L.P. | 0 0.000% | -4,026,417 (Position Closed) | View |
| 2024-08-08 4:48 pm Unchanged | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 4,328,883 7.700% | 0 (Unchanged) | View |
| 2024-05-29 4:35 pm Unchanged | 13D | Passage BIO Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 6.500% | 0 (Unchanged) | View |
| 2024-05-13 4:54 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 9.500% | 0 (Unchanged) | View |
| 2024-03-25 4:43 pm Purchase | 13D | LENZ Therapeutics Inc. LENZ | Versant Venture Capital VI L.P. | 2,101,199 8.200% | 2,101,199 (New Position) | View |
| 2024-02-08 5:44 pm Unchanged | 13D | ALIGOS THERAPEUTICS INC NE ALGS | Versant Venture Capital VI L.P. | 1,457,937 1.900% | 0 (Unchanged) | View |
| 2024-02-08 5:41 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 11.000% | 0 (Unchanged) | View |
| 2024-02-08 5:35 pm Unchanged | 13G | Century Therapeutics Inc. IPSC | Versant Venture Capital VI L.P. | 11,452,014 19.100% | 0 (Unchanged) | View |
| 2023-11-17 4:38 pm Unchanged | 13D | LENZ Therapeutics Inc. LENZ | Versant Venture Capital VI L.P. | 14,708,398 25.400% | 0 (Unchanged) | View |
| 2023-11-09 5:28 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 15.900% | 0 (Unchanged) | View |
| 2023-11-09 5:27 pm Unchanged | 13D | Passage BIO Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 7.300% | 0 (Unchanged) | View |
| 2023-11-09 5:26 pm Unchanged | 13D | Monte Rosa Therapeutics Inc. GLUE | Versant Venture Capital VI L.P. | 6,799,115 13.700% | 0 (Unchanged) | View |
| 2023-11-09 5:24 pm Unchanged | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 4,328,883 8.400% | 0 (Unchanged) | View |
| 2023-02-09 4:19 pm Sale | 13G | Century Therapeutics Inc. IPSC | Versant Venture Capital VI L.P. | 11,452,014 19.400% | -914,800 (-7.40%) | View |
| 2023-01-13 4:09 pm Sale | 13D | Oyster Point Pharma Inc. OYST | Versant Venture Capital VI L.P. | 0 0.000% | -2,236,888 (Position Closed) | View |